WDR81

Chr 17AR

WD repeat domain 81

Also known as: CAMRQ2, CHMRQ, HYC3, PPP1R166, SORF-2

This protein functions as a negative regulator of PI3 kinase activity on endosomal membranes and is required for endosome fusion, recycling, and early-to-late endosome transport, as well as aggrephagy of ubiquitinated protein aggregates. Biallelic mutations cause autosomal recessive cerebellar ataxia with impaired intellectual development and dysquilibrium syndrome (CAMRQ2) and congenital hydrocephalus with brain anomalies through loss-of-function mechanisms that disrupt endolysosomal trafficking. The gene shows moderate constraint against loss-of-function variants, consistent with recessive inheritance requiring biallelic mutations for disease manifestation.

OMIMResearchSummary from RefSeq, OMIM, UniProt
ARLOEUF 0.532 OMIM phenotypes
Clinical SummaryWDR81
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.53LOEUF
pLI 0.000
Z-score 4.57
OE 0.38 (0.270.53)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
2.11Z-score
OE missense 0.83 (0.790.87)
1000 obs / 1206.3 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.38 (0.270.53)
00.351.4
Missense OE0.83 (0.790.87)
00.61.4
Synonymous OE0.91
01.21.6
LoF obs/exp: 24 / 63.2Missense obs/exp: 1000 / 1206.3Syn Z: 1.60

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

WDR81 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →